TBAJ-876 displays bedaquiline-like mycobactericidal potency without retaining the parental drug's uncoupler activity

Jickky Palmae Sarathy, Priya Ragunathan, Christopher B. Cooper, Anna M. Upton, Gerhard Gruber*, Thomas Dick

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Abstract

The diarylquinoline F1FO-ATP synthase inhibitor bedaquiline (BDQ) displays protonophore activity. Thus, uncoupling electron transport from ATP synthesis appears to be a second mechanism of action of this antimycobacterial drug. Here, we show that the new BDQ analogue TBAJ-876 did not retain the parental drug's protonophore activity. Comparative time-kill analyses revealed that both compounds exert the same bactericidal activity. These results suggest that the uncoupler activity is not required for the bactericidal activity of diarylquinolines.

Original languageEnglish
Article numbere01540
JournalAntimicrobial Agents and Chemotherapy
Volume64
Issue number2
DOIs
Publication statusPublished - Jan 27 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020 American Society for Microbiology. All rights reserved.

ASJC Scopus Subject Areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Keywords

  • Bedaquiline
  • Protonophore
  • TBAJ-876
  • Tuberculosis
  • Uncoupler

Fingerprint

Dive into the research topics of 'TBAJ-876 displays bedaquiline-like mycobactericidal potency without retaining the parental drug's uncoupler activity'. Together they form a unique fingerprint.

Cite this